Urinary N-acetyl-β-d-Glucosaminidase Levels are Positively Correlated With 2-Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 6, 2012, Pages 473-480

  Ouchi, Motoshi ^a   Suzuki, Tatsuya ^a   Hashimoto, Masao ^a   Motoyama, Masayuki ^a   Ohara, Makoto ^a   Suzuki, Kazunari ^a   Igari, Yoshimasa ^a   Watanabe, Kentaro ^a   Nakano, Hiroshi ^a   Oba, Kenzo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cystatin C; Diabetic nephropathy; Impaired glucose tolerance; N acetyl d glucosaminidase; Tubular dysfunction

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; GLUCOSE; HEMOGLOBIN A1C; INSULIN; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CYSTATIN C; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDIABETIC STATE; STATISTICS, NONPARAMETRIC;

EID: 84869072637     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21549     Document Type: Article

References (40)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
2. Kowluru A, Kowluru R, Bitensky MW, Corwin EJ, Solomon SS, Johnson JD. Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria. J Exp Med 1987;166:1259-1279.
3. Kern EF, Erhard P, Sun W, Genuth S, Weiss MF. Early urinary markers of diabetic kidney disease: A nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis 2010;55:824-834.
4. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 1993;36:835-842.
5. Okazaki K, Oba K, Nakano H. Urinary N-acetyl-β-D-glucosaminidase activity predicts development of diabetic nephropathy. Geriatr Gerontol Int 2005;5:22-28.
6. Le Hir M, Dubach UC, Schmidt U. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry 1979;63:245-251.
7. Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H. Urinary excretion of N-acetyl-β-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum. Clin Chim Acta 1981;112:149-157.
8. Dance N, Price RG, Cattell WR, Lansdell J, Richards B. The excretion of N-acetyl-β-glucosaminidase and β-galactosidase by patients with renal disease. Clin Chim Acta 1970;27:87-92.
9. 2M) in evaluating nephrotoxicity of gentamicin. Clin Chim Acta 1981;116:25-34.
10. Sandman R, Margules RM, Kountz SL. Urinary lysosomal glycosidases after renal allotransplantation: Correlation of enzyme excretion with allograft rejection and ischemia. Clin Chim Acta 1973;45:349-359.
11. Ellis EN, Brouhard BH, Lagrone L, Travis LB. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type 1 diabetes mellitus. Diabetes Care 1983;6:251-255.
12. Martin P, Hampton KK, Walton C, Tindall H, Davies JA. Microproteinuria in type 2 diabetes mellitus from diagnosis. Diabet Med 1990;7:315-318
13. Yamanouchi T, Kawasaki T, Yoshimura T, et al. Relationship between serum 1, 5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up. Diabetes Care 1998;21:619-624.
14. Fujita H, Narita T, Morii T, et al. Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail 2002;24:69-75.
15. Hiratsuka N, Shiba K, Nishida K, Iizima S, Kimura M, Kobayashi S. Analysis of urinary albumin, transferrin, N-acetyl-β-D-glucosaminidase and β2-microglobulin in patients with impaired glucose tolerance. J Clin Lab Anal 1998;12:351-355.
16. Brouhard BH, LaGrone L, Travis LB, Pollard TG. Response of urinary N-acetyl-β-D-glucosaminidase to rapid decreases in blood glucose. Clin Chim Acta 1984;140:197-202.
17. Oba K, Igari Y, Matsumura N, et al. Effect of control of blood glucose on urinary excretion of N-acetyl-β-D-glucosaminidase in elderly type 2 diabetes mellitus. J Nippon Med Sch 2000;67:143-145.
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
19. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus; The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010;1:2-20.
20. Noto A, Ogawa Y, Mori S, et al. Simple, rapid spectrophotometry of urinary N-acetyl-β-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983;29:1713-1716.
21. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum Cr in Japan. Am J Kidney Dis 2009;53:982-992.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
23. Piwowar A, Knapik-Kordecka M, Fus I, Warwas M. Urinary activities of cathepsin B, N-acetyl-β-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus. Med Sci Monit 2006;12:CR210-CR214.
24. Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 2007;21:413-417.
25. Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011;34:975-981.
26. Basturk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A. Urinary N-acetyl β glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail 2006;28:125-128.
27. Agirbasli M, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS. Urinary N-acetyl-β-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. The Bogalusa Heart Study. Am J Hypertens 1996;9:157-161.
28. Oba K, Hirai M, Ajiro Y, et al. Effect of age on urinary excretion of N-acetyl-β-D-glucosaminidase. Nihon Ika Daigaku Zasshi 1999;66:33-36.
29. Dehne MG, Sablotzki A, Mühling J, Dehne KL, Röhrig R, Hempelmann G. Renal effects of cardiopulmonary bypass in the elderly. Perfusion 2002;17:205-209.
30. Sekikawa A, Tominaga M, Takahashi K, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993;16:570-574.
31. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
32. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69.
33. Stevic R, Zivkovic TB, Erceg P, Milosevic D, Despotovic N, Davidovic M. Oral glucose tolerance test in the assessment of glucose-tolerance in the elderly people. Age Ageing 2007;36:459-462.
34. DeFronzo RA. Glucose intolerance and aging. Diabetes Care 1981;4:493-501.
35. Yamanouchi T, Inoue T, Ogata E, et al. Post-load glucose measurements in oral glucose tolerance tests correlate well with 1, 5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance. Clin Sci (Lond) 2001;101:227-233.
36. Matsumoto K, Yano M, Miyake S, et al. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care 1998;21:256-260.
37. Stickle D, Turk J. A kinetic mass balance model for 1, 5-anhydroglucitol: Applications to monitoring of glycemic control. Am J Physiol 1997;273:E821-E830.
38. Alderman MH, Melcher L, Drayer DE, Reidenberg MM. Increased excretion of urinary N-acetyl-β-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med 1983;309:1213-1217.
39. Schnoell F, Weitgasser R, Straberger A, Pretsch I. Urinary activity of N-acetyl-β-D-glucosaminidase (NAG) in non-insulin-dependent diabetics (abstract). Diabetologia 1990;33:A153.
40. Sano T, Kawamura T, Matsumae H, et al. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diabetes Care 1994;17:420-424.